kabutan

JCR Pharmaceuticals Co.,Ltd.(4552) Summary

4552
TSE Prime
JCR Pharmaceuticals Co.,Ltd.
746
JPY
+14
(+1.91%)
Dec 12, 3:30 pm JST
4.78
USD
Dec 12, 1:30 am EST
Result
PTS
outside of trading hours
737
Dec 12, 11:50 pm JST
Summary Chart Historical News Financial Result
PER
30.3
PBR
1.89
Yield
2.68%
Margin Trading Ratio
17.02
Stock Price
Dec 12, 2025
Opening Dec 12, 9:00 am
746 JPY 4.79 USD
Previous Close Dec 11
732 JPY 4.68 USD
High Dec 12, 9:03 am
751 JPY 4.82 USD
Low Dec 12, 1:58 pm
733 JPY 4.70 USD
Volume
659,100
Trading Value
0.49B JPY 3.14M USD
VWAP
743.09 JPY 4.77 USD
Minimum Trading Value
74,600 JPY 478 USD
Market Cap
0.10T JPY 0.62B USD
Number of Trades
1,127
Liquidity & Number of Trades
As of Dec 12, 2025
Liquidity
High
1-Year Average
1,253
1-Year High Jun 2, 2025
15,312
Margin Trading
Date Short Interest Long Margin Positions Ratio
Dec 5, 2025 203,400 2,236,700 11.00
Nov 28, 2025 289,600 2,399,000 8.28
Nov 21, 2025 171,000 2,481,200 14.51
Nov 14, 2025 174,400 2,839,800 16.28
Nov 7, 2025 168,500 3,331,000 19.77
Company Profile
JCR Pharmaceuticals Co., Ltd. specializes in growth hormone products and focuses on biosimilars. The company collaborates with PeptiDream in creating carrier peptides.
Sector
Pharmaceuticals
JCR Pharmaceuticals Co., Ltd. develops, manufactures, and sells medical pharmaceuticals, regenerative medicine-related products, and pharmaceutical raw materials, primarily targeting rare disease areas. Through its group companies, the company engages in a wide range of activities including purchasing, facility management, market research, clinical trial supervision, pharmaceutical development, and intellectual property management. Internationally, JCR has subsidiaries in Brazil, Europe, and the United States, which handle clinical operations, regulatory affairs, and development tasks. The company also manages the distribution of pharmaceuticals and their raw materials, as well as contract manufacturing. JCR has affiliated companies involved in research and development, manufacturing, and sales in the regenerative medicine field, and has a proven track record in biosimilars.